This new data also extends the current view of Nogo-A as a major inhibitor of nerve growth and places a focus on its potential role in circumstances of hypoxic and oxidative stress, in particular stroke-induced ischaemia and neuroblastoma formation. This evidence concerns the gene RTN4 and stroke disorder.